Boardroom Alpha
Boardroom Alpha
ALKT · Current Report (Form 8-K) · Filed April 1, 2026

Alkami Technology Inc — Current Report (Form 8-K)

Form
8-K
Filed
April 1, 2026
Period
Mar 31, 2026
Ticker
ALKT
Accession
0001529274-26-000014
Boardroom Alpha · Filing insights

Alkami appoints Jeff Fox and Judson Linville to the Board, expanding to 11 directors post-Annual Meeting.

About Alkami Technology Inc
Market cap
$1.9B
1Y TSR
−41.1%
3Y TSR
+3.1%
Board grade
C
Sector
Technology
CEO
Alex Shootman
Last annual meeting: May 19, 2026 · View full Alkami Technology Inc profile →
alk-20260331

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): March 31, 2026

ALKAMI TECHNOLOGY, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware     001-40321     45-3060776
(State or Other Jurisdiction of Incorporation) (Commission File Number)     (I.R.S. Employer Identification Number)

5601 Granite Parkway, Suite 120, Plano, TX 75024
(Address of Principal Executive Offices) (Zip Code)
(877) 725-5264
Registrant’s Telephone Number, Including Area Code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareALKT
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
















Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 31, 2026, the Board of Directors (the “Board”) of Alkami Technology, Inc. (the “Company”) approved the appointment of Jeffrey (Jeff) Fox and Judson (Jud) Linville (Mr. Fox and Mr. Linville, collectively, the “New Directors”) to the Board, such appointments effective immediately following the conclusion of the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). Mr. Linville will serve as a Class III director of the Company with a term expiring at the Company’s 2027 annual meeting of stockholders, and Mr. Fox will serve as a Class I director of the Company with a term expiring at the Company’s 2028 annual meeting of stockholders, in each case until his successor has been duly elected and qualified, or, if sooner, until his earlier death, resignation or removal. In connection with the appointments of the New Directors to the Board, the Board approved an increase, effective immediately following the conclusion of the 2026 Annual Meeting, in the size of each of Class I and Class III from three to four directors such that the size of the Board will increase from nine directors to 11 directors. The Board will determine the committees on which the New Directors will serve upon or following the New Directors’ appointments to the Board.

Each New Director, following the effectiveness of his respective appointment to the Board, will receive compensation consistent with the Company’s compensation program for non-employee directors, as described in the Company’s proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 31, 2025. There are no transactions or relationships between the New Directors and the Company that would be reportable under Item 404(a) of Regulation S-K. Additional information regarding the New Directors is included below.

Judson Linville

Mr. Linville is a public company executive and senior advisor with more than 30 years of experience in the financial services and technology sectors. Mr. Linville was most recently a senior advisor at General Atlantic LLC, a global growth equity firm, from 2019 until 2024. From 2010 to 2018, Mr. Linville was the Chief Executive Officer for Global Cards and Consumer Services at Citigroup Inc., a publicly traded global financial services institution, where he led the global credit card franchise, representing approximately $13 billion in revenue and 55 million individual and small business customers across 18 countries. Prior to his role at Citigroup, Mr. Linville spent more than two decades at American Express where he held the role of President and Chief Executive Officer for Consumer Card Services and served on the six-person management team that set the strategic direction for the company. Mr. Linville currently serves on the board of directors of Marqeta, Inc. (NASDAQ: MQ), a financial technology company that provides a cloud-based, open API platform for modern card issuing and transaction processing. Mr. Linville holds a Doctor of Psychology in Clinical Psychology from the College of Medicine at Drexel University and a Bachelor of Arts in Psychology from Lafayette College.

Jeffrey Fox

Jeffrey Fox is the CEO and Founder of Circumference Group LLC, an investment firm where he oversees the firm’s management and business strategy. He most recently served as President and Chief Executive Officer of Endurance International Group Holdings, Inc. Prior to joining Endurance, Mr. Fox served as President and CEO of Convergys Corporation and, before Convergys, held multiple positions at Alltel Corporation. Mr. Fox currently serves on the boards of Penn Entertainment, Inc. (NASDAQ: PENN), Westrock Coffee Company (NASDAQ: WEST), Resources Connection Inc. (NASDAQ: RGP). His previous board roles include Avis Budget Group (NASDAQ: CAR). Mr. Fox began his career in investment banking at Merrill Lynch and Stephens Inc. He holds a Bachelor of Arts in Economics from Duke University.



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Alkami Technology, Inc.
Date:April 1, 2026By:/s/ Cassandra Hudson
Cassandra Hudson
Chief Financial Officer

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Alkami Technology Inc (ALKT)

Reference

Frequently asked questions

When did Alkami Technology Inc file this 8-K?
Alkami Technology Inc (ALKT) filed this Current Report (Form 8-K) with the SEC on April 1, 2026. The accession number assigned by EDGAR is 0001529274-26-000014.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Alkami appoints Jeff Fox and Judson Linville to the Board, expanding to 11 directors post-Annual Meeting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Alkami Technology Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Alkami Technology Inc has filed under CIK 1529274, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer